Atomoxetine Capsules Recalled for Manufacturing Impurity Above Limits
Glenmark Pharmaceuticals is recalling Atomoxetine Capsules, 60 mg due to N-Nitroso Atomoxetine impurity above FDA-recommended limits. Approximately 53,952 bottles were distributed nationwide.
- Product
- ATOMOXETINE — ATOMOXETINE (ATOMOXETINE)
- Category
- Drug
- Distribution
- Distributed nationwide